SEC
Fundamental Analysis
2 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTMXCytomX Therapeutics, Inc. | 57.3 | 0 | 0 | 76 | -75.95% | n/a | n/a | +69.73% | +151.22% | 0% | 0 | n/a | n/a | Net debt reduction3 warnings |
| CTMCastellum, Inc. | 42.5 | 100 | 100 | 76 | +23.13% | -8.59% | n/a | n/a | +16.98% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
1-2 of 2